Immunogenic Biologics: Validation of Screening, Deimmunization and Tolerization Approaches

by Adam | Oct 21, 2016

Immunogenicity Analysis of Chinese Hamster Ovary (CHO) Host Cell Protein Contaminants in Therapeutic Protein Formulations

by Adam | Oct 21, 2016

In-silico prediction of HLA-DP and -DQ epitope content is poorly correlated with clinical immunogenicity of therapeutic proteins

by Adam | Oct 21, 2016

T-Cell Dependent Immunogenicity of Protein Therapeutics: Preclinical Assessment and Mitigation

by Adam | Oct 21, 2016

Tolerization as a Rational Design Approach for Reducing the Immunogenicity of Biologics (Campath)

by Adam | Oct 21, 2016